Vimarsana
Biggest News Aggregation in the World

Page 30 - Technology Organization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Organization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Organization Today - Breaking & Trending Today

Inside China's shadowy bioweapons unit 'creating weaponised coronaviruses, bacteria bombs and anthrax ready for WW3' - Vimarsana News

Inside China's shadowy bioweapons unit 'creating weaponised coronaviruses, bacteria bombs and anthrax ready for WW3'

CHINA is feared to have spent decades illicitly researching biological weapons at dozens of secretive sites ahead of a potential apocalyptic World War

The best defense: Why NATO should invest in resilience - Vimarsana News

The best defense: Why NATO should invest in resilience

NATO can play a critical role in the relationship- and capacity-building necessary for a healthy global biosecurity sphere.

MorphoSys AG: MorphoSys to Acquire Constellation Pharmaceuticals - Vimarsana News

MorphoSys AG: MorphoSys to Acquire Constellation Pharmaceuticals

Accelerates Growth Strategy by Adding Two Mid- to Late-Stage Product Candidates: Pelabresib (CPI-0610) and CPI-0209 Bolsters Position in Hematology-Oncology and Expands into Solid Tumors Best-in-Class

[과학기술이 미래다] 5 과학기술 기구 설립 시동 - Vimarsana News

[과학기술이 미래다] 5 과학기술 기구 설립 시동

세상 일에는 미처 예상하지 못한 상황 반전(反轉)이 있다. 과학기술 행정기구 설립 추진도 반전 가운데 하나다. 과학기술 행정 전담 기구는 1961년까지 문교부(현 교육부)가 주관해 설립을 추진했다. 문교부는 과학...

Source: etnews.com
"Characterization of a novel large area microdosimeter system for low d" by Vladimir A. Pan, Federico Pagani et al. - Vimarsana News

"Characterization of a novel large area microdosimeter system for low d" by Vladimir A. Pan, Federico Pagani et al.

Abstract A feasibility study is presented on a newly developed microdosimetry system named Octobox, for its application in low dose rate, mixed radiation environments. A full characterization of the device was performed at the Heavy Ion Medical Accelerator in Chiba (HIMAC), Japan, out-of-field of various heavy ion radiation fields — 290 MeV/u C, 230 MeV/u and 490 MeV/u Si and 400 MeV/u Ne ions, as well as a low dose rate Rn environment at the Australian Nuclear Sciences and Technology Organization (ANSTO). The device was shown to collect adequate statistics in a short period of time whe...

Source: uow.edu.au